102 related articles for article (PubMed ID: 23333207)
1. Synthesis and biological evaluation of 2-(arylethynyl)quinoline derivatives as mGluR5 antagonists for the treatment of neuropathic pain.
Son MH; Kim JY; Lim EJ; Baek DJ; Choi K; Lee JK; Pae AN; Min SJ; Cho YS
Bioorg Med Chem Lett; 2013 Mar; 23(5):1472-6. PubMed ID: 23333207
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of 2-substituted quinoline 6-carboxamides as potential mGluR1 antagonists for the treatment of neuropathic pain.
Kim Y; Son J; Kim J; Baek DJ; Lee YS; Lim EJ; Lee JK; Pae AN; Min SJ; Cho YS
Chem Pharm Bull (Tokyo); 2014; 62(6):508-18. PubMed ID: 24881656
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of picolinamides and thiazole-2-carboxamides as mGluR5 (metabotropic glutamate receptor 5) antagonists.
Vu HN; Kim JY; Hassan AH; Choi K; Park JH; Park KD; Lee JK; Pae AN; Choo H; Min SJ; Cho YS
Bioorg Med Chem Lett; 2016 Jan; 26(1):140-4. PubMed ID: 26598462
[TBL] [Abstract][Full Text] [Related]
4. Positive and negative modulation of group I metabotropic glutamate receptors.
Vanejevs M; Jatzke C; Renner S; Müller S; Hechenberger M; Bauer T; Klochkova A; Pyatkin I; Kazyulkin D; Aksenova E; Shulepin S; Timonina O; Haasis A; Gutcaits A; Parsons CG; Kauss V; Weil T
J Med Chem; 2008 Feb; 51(3):634-47. PubMed ID: 18173231
[TBL] [Abstract][Full Text] [Related]
5. Potent mGluR5 antagonists: pyridyl and thiazolyl-ethynyl-3,5-disubstituted-phenyl series.
Alagille D; DaCosta H; Chen Y; Hemstapat K; Rodriguez A; Baldwin RM; Conn PJ; Tamagnan GD
Bioorg Med Chem Lett; 2011 Jun; 21(11):3243-7. PubMed ID: 21546249
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, structure-activity relationship, and receptor pharmacology of a new series of quinoline derivatives acting as selective, noncompetitive mGlu1 antagonists.
Mabire D; Coupa S; Adelinet C; Poncelet A; Simonnet Y; Venet M; Wouters R; Lesage AS; Van Beijsterveldt L; Bischoff F
J Med Chem; 2005 Mar; 48(6):2134-53. PubMed ID: 15771457
[TBL] [Abstract][Full Text] [Related]
7. 4-Aryl-3-arylsulfonyl-quinolines as negative allosteric modulators of metabotropic GluR5 receptors: From HTS hit to development candidate.
Galambos J; Domány G; Nógrádi K; Wágner G; Keserű GM; Bobok A; Kolok S; Mikó-Bakk ML; Vastag M; Sághy K; Kóti J; Szakács Z; Béni Z; Gál K; Szombathelyi Z; Greiner I
Bioorg Med Chem Lett; 2016 Feb; 26(4):1249-52. PubMed ID: 26774652
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of new 2-chloro-3-((4-phenyl-1H-1,2,3-triazol-1-yl)methyl)quinoline derivatives via click chemistry approach.
Kategaonkar AH; Shinde PV; Kategaonkar AH; Pasale SK; Shingate BB; Shingare MS
Eur J Med Chem; 2010 Jul; 45(7):3142-6. PubMed ID: 20435389
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of quinoline amide derivatives as novel VEGFR-2 inhibitors.
Yang Y; Shi L; Zhou Y; Li HQ; Zhu ZW; Zhu HL
Bioorg Med Chem Lett; 2010 Nov; 20(22):6653-6. PubMed ID: 20943391
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of antibacterial activity of 7-alkyloxy-4,5-dihydro-imidazo[1,2-a]quinoline derivatives.
Sun XY; Wu R; Wen X; Guo L; Zhou CP; Li J; Quan ZS; Bao J
Eur J Med Chem; 2013 Feb; 60():451-5. PubMed ID: 23321259
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and structure-activity relationship of 4-(2-aryl-cyclopropylamino)-quinoline-3-carbonitriles as EGFR tyrosine kinase inhibitors.
Pannala M; Kher S; Wilson N; Gaudette J; Sircar I; Zhang SH; Bakhirev A; Yang G; Yuen P; Gorcsan F; Sakurai N; Barbosa M; Cheng JF
Bioorg Med Chem Lett; 2007 Nov; 17(21):5978-82. PubMed ID: 17827009
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and anticancer evaluation of certain 4-anilinofuro[2,3-b]quinoline and 4-anilinofuro[3,2-c]quinoline derivatives.
Chen YL; Chen IL; Wang TC; Han CH; Tzeng CC
Eur J Med Chem; 2005 Sep; 40(9):928-34. PubMed ID: 15913847
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of new 4-carboxyl quinoline derivatives as cyclooxygenase-2 inhibitors.
Zarghi A; Ghodsi R; Azizi E; Daraie B; Hedayati M; Dadrass OG
Bioorg Med Chem; 2009 Jul; 17(14):5312-7. PubMed ID: 19560931
[TBL] [Abstract][Full Text] [Related]
14. C-C bond formation at C-2 of a quinoline ring: synthesis of 2-(1H-indol-3-yl)quinoline-3-carbonitrile derivatives as a new class of PDE4 inhibitors.
Kumar KS; Kiran Kumar S; Yogi Sreenivas B; Gorja DR; Kapavarapu R; Rambabu D; Rama Krishna G; Reddy CM; Basaveswara Rao MV; Parsa KV; Pal M
Bioorg Med Chem; 2012 Apr; 20(7):2199-207. PubMed ID: 22386978
[TBL] [Abstract][Full Text] [Related]
15. Discovery of 4-amino-3-arylsulfoquinolines, a novel non-acetylenic chemotype of metabotropic glutamate 5 (mGlu
Galambos J; Bielik A; Wágner G; Domány G; Kóti J; Béni Z; Szigetvári Á; Sánta Z; Orgován Z; Bobok A; Kiss B; Mikó-Bakk ML; Vastag M; Sághy K; Krasavin M; Gál K; Greiner I; Szombathelyi Z; Keserű GM
Eur J Med Chem; 2017 Jun; 133():240-254. PubMed ID: 28390229
[TBL] [Abstract][Full Text] [Related]
16. Potentiation of morphine antiallodynic efficacy by ACPT-III, a group III metabotropic glutamate receptor agonist, in rat spinal nerve ligation-induced neuropathic pain.
Lee HG; Park SK; Yoon MH
Pharmacol Biochem Behav; 2010 Jul; 96(1):108-13. PubMed ID: 20434481
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of some quinoline-2(1H)-one and 1, 2, 4 - triazolo [ 4 , 3 -a ] quinoline derivatives as potent anticonvulsants.
Guan LP; Jin QH; Tian GR; Chai KY; Quan ZS
J Pharm Pharm Sci; 2007; 10(3):254-62. PubMed ID: 17727789
[TBL] [Abstract][Full Text] [Related]
18. Comparative in vitro studies of MR imaging probes for metabotropic glutamate subtype-5 receptor targeting.
Gottschalk S; Engelmann J; Rolla GA; Botta M; Parker D; Mishra A
Org Biomol Chem; 2013 Sep; 11(36):6131-41. PubMed ID: 23925571
[TBL] [Abstract][Full Text] [Related]
19. Novel transient receptor potential vanilloid 1 receptor antagonists for the treatment of pain: structure-activity relationships for ureas with quinoline, isoquinoline, quinazoline, phthalazine, quinoxaline, and cinnoline moieties.
Gomtsyan A; Bayburt EK; Schmidt RG; Zheng GZ; Perner RJ; Didomenico S; Koenig JR; Turner S; Jinkerson T; Drizin I; Hannick SM; Macri BS; McDonald HA; Honore P; Wismer CT; Marsh KC; Wetter J; Stewart KD; Oie T; Jarvis MF; Surowy CS; Faltynek CR; Lee CH
J Med Chem; 2005 Feb; 48(3):744-52. PubMed ID: 15689158
[TBL] [Abstract][Full Text] [Related]
20. Quinoline tricyclic derivatives. Design, synthesis and evaluation of the antiviral activity of three new classes of RNA-dependent RNA polymerase inhibitors.
Carta A; Briguglio I; Piras S; Corona P; Boatto G; Nieddu M; Giunchedi P; Marongiu ME; Giliberti G; Iuliano F; Blois S; Ibba C; Busonera B; La Colla P
Bioorg Med Chem; 2011 Dec; 19(23):7070-84. PubMed ID: 22047799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
